United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

salmon) 400units/2ml solution for injection vials (alliance healthcare (distribution) ltd - calcitonin (salmon) - solution for injection - 200unit/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

salmon) 50units/1ml solution for injection ampoules (a a h pharmaceuticals ltd - calcitonin (salmon) - solution for injection - 50unit/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

salmon) 400units/2ml solution for injection vials (a a h pharmaceuticals ltd - calcitonin (salmon) - solution for injection - 200unit/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

salmon) 100units/1ml solution for injection ampoules (a a h pharmaceuticals ltd - calcitonin (salmon) - solution for injection - 100unit/1ml

Israel - English - Ministry of Health

biovac ltd, israel - colistin as sulfate 2 miu/ml - solution (oral) - treatment of infections in the gastrointestinol tract caused by gram negative bacteria as salmonella,e. coli and other bacteria, sensitive to colistin in turkey.

Philippines - English - FDA (Food And Drug Administration)

avli biocare inc. - colistin , amoxicillin , attapulgite , neomycin , electroytes - oral suspension (raspberry flavor) - formulation: each ml contains: colistin ......... 25 iu amoxicillin (as trihydrate) ............ 1 mg neomycin (as sulfate) ................. 330 ug attapulgite ....... 1 mg potassium chloride ... 375 ug sodium chloride ........ 250 ug magnesium sulfate....... 75 ug

Malta - English - Medicines Authority

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - colistin mesilate, sodium - powder and solvent for solution for infusion or injection - colistin mesilate sodium 1000000 iu - antibacterials for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

essential pharma ltd - calcitonin, salmon - solution for injection/infusion - 100 international unit(s)/millilitre - calcitonin preparations; calcitonin (salmon synthetic)

United States - English - NLM (National Library of Medicine)

mylan institutional llc - calcitonin salmon (unii: 7sfc6u2vi5) (calcitonin salmon - unii:7sfc6u2vi5) - miacalcin injection is indicated for the treatment of symptomatic paget’s disease of bone in patients with moderate to severe disease characterized by polyostotic involvement with elevated serum alkaline phosphatase and urinary hydroxyproline excretion. there is no evidence that the prophylactic use of calcitonin salmon is beneficial in asymptomatic patients. miacalcin injection should be used only in patients who do not respond to alternative treatments or for whom such treatments are not suitable (e.g., patients for whom other therapies are contraindicated or for patients who are intolerant or unwilling to use other therapies). miacalcin injection is indicated for the early treatment of hypercalcemic emergencies, along with other appropriate agents, when a rapid decrease in serum calcium is required, until more specific treatment of the underlying disease can be accomplished. it may also be added to existing therapeutic regimens for hypercalcemia such as intravenous fluids and furosemide, oral phosphate or

United States - English - NLM (National Library of Medicine)

mylan institutional llc - calcitonin salmon (unii: 7sfc6u2vi5) (calcitonin salmon - unii:7sfc6u2vi5) - miacalcin injection is indicated for the treatment of symptomatic paget’s disease of bone in patients with moderate to severe disease characterized by polyostotic involvement with elevated serum alkaline phosphatase and urinary hydroxyproline excretion. there is no evidence that the prophylactic use of calcitonin salmon is beneficial in asymptomatic patients. miacalcin injection should be used only in patients who do not respond to alternative treatments or for whom such treatments are not suitable (e.g., patients for whom other therapies are contraindicated or for patients who are intolerant or unwilling to use other therapies). miacalcin injection is indicated for the early treatment of hypercalcemic emergencies, along with other appropriate agents, when a rapid decrease in serum calcium is required, until more specific treatment of the underlying disease can be accomplished. it may also be added to existing therapeutic regimens for hypercalcemia such as intravenous fluids and furosemide, oral phosphate or